Company
Forus
AI-powered platform that helps patients with high-cost and complex conditions access medications faster and more affordably, while enabling life science companies to bring drugs to market more efficiently through a two-sided network of doctors, patients, and clinical data
Data & AnalyticsHealthcare & BiotechAIEnterprise Software
People
Funding History
May 12, 2026
Forus raised $160M at a $1B valuation in its first public announcement, coming out of stealth. Investors include Thrive Capital, General Catalyst, and Accel.
Sep 8, 2026Series C
Forus raised a $150M Series C at a $3B valuation. The company's AI Network for Medicine now supports millions of patients across all 50 US states, covers 85% of US residential ZIP codes, and works with 9 of the top 15 global biopharma companies.